Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.003 seconds).
Item hits:
Issue DateTitleAuthor(s)
2020Antifungal Activity and the Chemical and Physical Stability of Microemulsions Containing Citrus hystrix DC Leaf OilPumival P.; Tadtong S.; Athikomkulchai S.; Chittasupho C.
2020Stability, permeation, and cytotoxicity reduction of capsicum extract nanoparticles loaded hydrogel containing wax gourd extractChittasupho C.; Thongnopkoon T.; Burapapisut S.; Charoensukkho C.; Shuwisitkul D.; Samee W.
2012Biodegradable nanoparticles surface modification techniques with cIBR peptide targeting to LFA-1 expressing leukemic cellsPhongpradist R.; Chittasupho C.; Intasai N.; Siahaan T.J.; Berkland C.J.; Charoenkwan P.; Anuchapreeda S.; Ampasavate C.
2012Multivalent ligand: Design principle for targeted therapeutic delivery approachChittasupho C.
2014Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticlesChittasupho C.; Lirdprapamongkol K.; Kewsuwan P.; Sarisuta N.
2017CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibitionChittasupho C.; Anuchapreeda S.; Sarisuta N.
2020Anti-angiogenesis by dual action of R5K peptide conjugated itraconazole nanoparticlesChittasupho C.; Kengtrong K.; Chalermnithiwong S.; Sarisuta N.
2017CXCR4-targeted nanoparticles reduce cell viability, induce apoptosis and inhibit SDF-1α induced BT-549-Luc cell migration in vitroChittasupho C.; Kewsuwan P.; Murakami T.
2013Pectin nanoparticle enhances cytotoxicity of methotrexate against hepG2 cellsChittasupho C.; Jaturanpinyo M.; Mangmool S.
2018Doxorubicin-loaded micelle targeting MUC1: A potential therapeutic for MUC1 triple negative breast cancer treatmentKhondee S.; Chittasupho C.; Tima S.; Anuchapreeda S.